Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Analysis
  4. Volume 20, Issue 7
  5. Article
Volume 20, Issue 7
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Background

Quercetin is a flavanol that has demonstrated pharmaceutical properties such as anti-inflammatory, antioxidant, and anti-carcinogenic properties. However, parenteral formulations of quercetin are currently not in widespread use due to its poor aqueous solubility, fast metabolism, and low bioavailability.

Objective

This study aimed to develop a quick, simple, and accurate method for the quantification of quercetin using ultra-fast liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Methods

A rapid and sensitive LC-MS/MS method was developed and fully validated for the quantification of quercetin in rat plasma after intravenous administration. Quercetin reference standard was used for the method development as well as validation. ACQUITY UPLC BEH C18 Column (2.1 x 50 mm, 1.7 µm) was used for the chromatographic separation. The mobile phase consisted of solution A (water with 0.1% formic acid) and solution B (methanol: acetonitrile with 0.1% formic acid in the ratio of 1:1) with a flow rate of 0.350 µL/min. Further, the method was applied to quantify and pharmacokineticly profile quercetin in the blood plasma of outbred male and female Wistar rats.

Results

The accuracy of the method was calculated for intraday and inter-day, which came out as ≤ 85.23% and 84.87%, respectively. The precision of the method calculated for intraday was ≤3.02%, and for inter-day was ≤2.75%. The percentage recovery was found to be ≤85.23% for intraday and ≤84.87% for inter-day. The Relative Standard Deviation was 0.04 for intraday and 1.10 for inter day, respectively.

Conclusion

The developed method has an advantage over other reported methods because of its short run time of 6 minutes as well as its short time of data registration of approximately 2.5 minutes. This method can be used for the routine analysis of quercetin animal studies.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129309138240812101759
2024-08-19
2025-01-22

  • From This Site

    /content/journals/cpa/10.2174/0115734129309138240812101759
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LigaS. PaulC. PéterF. Flavonoids: Overview of biosynthesis, biological activity, and current extraction techniques.Plants20231214273210.3390/plants1214273237514347
     [Google Scholar]
  2. BatihaG.E.S. BeshbishyA.M. IkramM. MullaZ.S. El-HackM.E.A. TahaA.E. AlgammalA.M. ElewaY.H.A. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: Quercetin.Foods20209337410.3390/foods903037432210182
     [Google Scholar]
  3. ParasuramanS. Anand DavidA.V. ArulmoliR. Overviews of biological importance of quercetin: A bioactive flavonoid.Pharmacogn. Rev.20161020848910.4103/0973‑7847.19404428082789
     [Google Scholar]
  4. Toxicology and carcinogenesis studies of quercetin (CAS No. 117-39-5) in F344 rats (Feed Studies).Natl Toxicol Program Tech Rep Ser19924091171
     [Google Scholar]
  5. NabaviS.F. RussoG.L. DagliaM. NabaviS.M. Role of quercetin as an alternative for obesity treatment: You are what you eat!Food Chem.201517930531010.1016/j.foodchem.2015.02.00625722169
     [Google Scholar]
  6. KentT. A novel injectable formulation of quercetin reliant on the ability of the drug to complex copper.Cancer Res.2016762178
     [Google Scholar]
  7. DayA.J. MellonF. BarronD. SarrazinG. MorganM.R.A. WilliamsonG. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin.Free Radic. Res.200135694195210.1080/1071576010030144111811545
     [Google Scholar]
  8. WittigJ. HerderichM. GraefeE.U. VeitM. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography–tandem mass spectrometry.J. Chromatogr., Biomed. Appl.2001753223724310.1016/S0378‑4347(00)00549‑111334336
     [Google Scholar]
  9. HongY.J. MitchellA.E. Metabolic profiling of flavonol metabolites in human urine by liquid chromatography and tandem mass spectrometry.J. Agric. Food Chem.200452226794680110.1021/jf040274w15506818
     [Google Scholar]
  10. ManachC. MorandC. CrespyV. DemignéC. TexierO. RégératF. RémésyC. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties.FEBS Lett.1998426333133610.1016/S0014‑5793(98)00367‑69600261
     [Google Scholar]
  11. JustinoG.C. SantosM.R. CanárioS. BorgesC. FlorêncioM.H. MiraL. Plasma quercetin metabolites: Structure–antioxidant activity relationships.Arch. Biochem. Biophys.2004432110912110.1016/j.abb.2004.09.00715519302
     [Google Scholar]
  12. LarsonA.J. SymonsJ.D. JaliliT. Therapeutic potential of quercetin to decrease blood pressure: Review of efficacy and mechanisms.Adv. Nutr.201231394610.3945/an.111.00127122332099
     [Google Scholar]
  13. ManachC. WilliamsonG. MorandC. ScalbertA. RémésyC. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.Am. J. Clin. Nutr.2005811Suppl.230S242S10.1093/ajcn/81.1.230S15640486
     [Google Scholar]
  14. LodiF. JimenezR. MorenoL. KroonP.A. NeedsP.W. HughesD.A. Santos-BuelgaC. Gonzalez-ParamasA. CogolludoA. Lopez-SepulvedaR. DuarteJ. Perez-VizcainoF. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta.Atherosclerosis20092041343910.1016/j.atherosclerosis.2008.08.00718801486
     [Google Scholar]
  15. Boesch-SaadatmandiC. LobodaA. WagnerA.E. StachurskaA. JozkowiczA. DulakJ. DöringF. WolfframS. RimbachG. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155.J. Nutr. Biochem.201122329329910.1016/j.jnutbio.2010.02.00820579867
     [Google Scholar]
  16. ManachC. MorandC. DemignéC. TexierO. RégératF. RémésyC. Bioavailability of rutin and quercetin in rats.FEBS Lett.19974091121610.1016/S0014‑5793(97)00467‑59199494
     [Google Scholar]
  17. V.D.K. VermaP.R.P. SinghS.K. ViswanathanS. LC-ESI-MS/MS analysis of quercetin in rat plasma after oral administration of biodegradable nanoparticles.Biomed. Chromatogr.201529111731173610.1002/bmc.348625973544
     [Google Scholar]
  18. ICH Q2(R1) Validation of analytical procedures: Text and methodology.2005Available from: https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf
  19. LiY. YaoJ. HanC. YangJ. ChaudhryM. WangS. LiuH. YinY. Quercetin, inflammation and immunity.Nutrients20168316710.3390/nu803016726999194
     [Google Scholar]
  20. XuD. HuM.J. WangY.Q. CuiY.L. Antioxidant activities of quercetin and its complexes for medicinal application.Molecules2019246112310.3390/molecules2406112330901869
     [Google Scholar]
  21. SrinivasK. KingJ.W. HowardL.R. MonradJ.K. Solubility and solution thermodynamic properties of quercetin and quercetin dihydrate in subcritical water.J. Food Eng.2010100220821810.1016/j.jfoodeng.2010.04.001
     [Google Scholar]
  22. AbdelkawyK.S. BalyshevM.E. ElbarbryF. A new validated HPLC method for the determination of quercetin: Application to study pharmacokinetics in rats.Biomed. Chromatogr.2017313e381910.1002/bmc.381927555122
     [Google Scholar]
  23. LiuP. ZouD. YiL. ChenM. GaoY. ZhouR. ZhangQ. ZhouY. ZhuJ. ChenK. MiM. Quercetin ameliorates hypobaric hypoxia-induced memory impairment through mitochondrial and neuron function adaptation via the PGC-1α pathway.Restor. Neurol. Neurosci.201533214315710.3233/RNN‑14044625588463
     [Google Scholar]
  24. WangL. MorrisM. Liquid chromatography–tandem mass spectroscopy assay for quercetin and conjugated quercetin metabolites in human plasma and urine.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2005821219420110.1016/j.jchromb.2005.05.00915925552
     [Google Scholar]
  25. NiB. CaoS. FengL. YinX. WangW. ZhangX. NiJ. Simultaneous Analysis of Quercetin and Naringenin in Rat Plasma by Liquid Chromatography–Tandem Mass Spectrometry: Application to a Pharmacokinetic Study After Oral Administration.J. Chromatogr. Sci.20165481359136410.1093/chromsci/bmw07927199443
     [Google Scholar]
/content/journals/cpa/10.2174/0115734129309138240812101759
Loading
Method Development and Validation for Quantification of Quercetin in Blood Plasma of Wistar Rats Using LC-MS/MS
Current Pharmaceutical Analysis 20, 576 (2024); https://doi.org/10.2174/0115734129309138240812101759
/content/journals/cpa/10.2174/0115734129309138240812101759
/content/journals/cpa/10.2174/0115734129309138240812101759
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): bioavailability; Intravenous; LC-MS/MS; pharmacokinetics; quercetin; rat

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test